宫内或生命早期抗生素暴露与儿童特应性皮炎风险的人群队列研究
该基于人群的队列研究利用大型前瞻性电子病历数据库,评估胎儿期或生命早期抗生素暴露与儿童早发性特应性皮炎(AD)风险的关联。结果显示,宫内任何抗生素暴露的HR为1.38(95%CI 1.36-1.39),青霉素关联最强;生命早期抗生素暴露的AD风险增加40-80%,且母体AD病史存在效应修饰。
要点
- 宫内任何抗生素暴露与儿童AD风险升高相关,HR为1.38(95%CI 1.36-1.39)。
- 青霉素在宫内暴露[HR 1.43(1.41-1.44)]和儿童期暴露[HR 1.81(1.79-1.82)]中关联最强。
- 母体无AD的儿童中HR高于母体有AD者,提示母体AD病史存在效应修饰。
核心结论
- 宫内抗生素暴露儿童根据母体AD病史约增加20-40%的AD风险,生命早期抗生素暴露根据抗生素种类增加40-80%的AD风险。
- 研究支持并细化了AD发生与抗生素给药之间的关联,并为通过调节皮肤微生物组治疗AD的尝试提供了人群水平支持。
研究设计与样本
- 利用大型前瞻性收集的电子病历数据库进行基于人群的队列研究。
- 采用比例风险模型估计风险比(HR)及95%置信区间(CI)。
主要发现
- 宫内任何抗生素暴露的AD风险HR为1.38(95%CI 1.36-1.39)。
- 青霉素与AD关联最强:宫内暴露HR为1.43(95%CI 1.41-1.44),儿童期暴露HR为1.81(95%CI 1.79-1.82)。
- 母体无AD的儿童中HR高于母体有AD者,提示母体AD病史存在效应修饰。
临床怎么用
- 研究结果支持并细化了AD发生与抗生素给药之间的关联。
- 为通过调节皮肤微生物组治疗AD的尝试提供了人群水平支持。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a common inflammatory disease of the skin that begins early in life and can be lifelong. The purpose of our study was to evaluate whether fetal exposure and/or early-life exposure of a child to antibiotics increases the risk of early-onset AD. OBJECTIVES: We hypothesize that antibiotic exposure in utero or early in life (e.g. first 90 days) increases the likelihood that children develop AD. METHODS: Utilizing a large, prospectively collected electronic medical records database, we studied the association of antibiotic exposure received in utero or very early in life and the relative risk of onset of AD in a population-based cohort study. Associations were estimated using proportional hazards models as hazard ratios (HRs) with 95% confidence intervals (CIs). RESULTS: The risk of AD in childhood was increased after in utero or early-life antibiotic exposure. For any in utero antibiotic exposure the HR (CI) was 1.38 (1.36-1.39). However, penicillin demonstrated the strongest association with AD for both in utero exposure [1.43 (1.41-1.44)] and for childhood exposure [1.81 (1.79-1.82)]. HRs were higher in children born to mothers without AD than in those with AD pointing to effect modification by maternal AD status. CONCLUSIONS: Children born to mothers exposed to antibiotics while in utero had, depending on the mother's history of AD, approximately a 20-40% increased risk of developing AD. Depending on the antibiotic, children who received antibiotics early in life had a 40-80% increased risk of developing AD. Our study supports and refines the association between incident AD and antibiotic administration. It also adds population-based support to therapeutic attempts to treat AD by modifying the skin microbiome.
引用
- Fuxench ZC, Mitra N, Del Pozo D, et al. In utero or early-in-life exposure to antibiotics and the risk of childhood atopic dermatitis, a population-based cohort study. Br J Dermatol. 2024. PMID: 37897530. doi:10.1093/bjd/ljad428
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。